J01CR02 |
B |
Amoxicillin (trihydrate) - 600mg/5ml, Clavulanic Acid (potassium) - 42.9mg/5ml |
6251 |
166503/11 |
AUGMENTIN ES |
642.9mg/5ml |
100ml |
Powder for suspension |
Oral |
Abela Fr |
GlaxoWellcome Production |
France |
846,621 L.L |
23.08 |
A2 |
GlaxoSmithKline Produtos Farmaceuticos Lda |
Portugal |
03/04/20 |
|
J01CR02 |
G |
Amoxicillin (trihydrate) - 600mg/5ml, Clavulanic Acid (potassium) - 42.9mg/5ml |
7025 |
96599/12 |
JULMENTIN ES |
642.9mg/5ml |
100ml |
Powder for suspension |
Oral |
Pharmanet Drugstore S.A.R.L. |
Julphar |
United Arab Emirates |
507,972 L.L |
23.08 |
A1 |
Julphar |
United Arab Emirates |
03/04/20 |
|
J01CR02 |
G |
Amoxicillin - 600mg/5ml, Clavulanic Acid - 42.9mg/5ml |
10860 |
28820/1 |
BETAMOX ES |
|
100ml |
Powder for suspension |
Oral |
Pharmamedic S.A.R.L. |
Laboratorios Atral SA |
Portugal |
592,635 L.L |
23.08 |
A1 |
Laboratorios Atral SA |
Portugal |
03/04/20 |
|
J01CR02 |
G |
Amoxicillin (trihydrate) - 600mg/5ml, Clavulanic Acid (potassium) - 42.9mg/5ml |
11609 |
132320/0 |
MEGAMOX-JPI ES |
600mg |
100ml |
Powder for suspension |
Oral |
Droguerie de l'Union |
Jazeera Pharmaceutical Industries |
Saudi Arabia |
507,972 L.L |
23.08 |
A1 |
Jazeera Pharmaceutical Industries |
Saudi Arabia |
03/04/20 |
|